Invention Grant
- Patent Title: Triazolopyridine compounds as PIM kinase inhibitors
- Patent Title (中): 三唑并吡啶化合物作为PIM激酶抑制剂
-
Application No.: US14057882Application Date: 2013-10-18
-
Publication No.: US08987251B2Publication Date: 2015-03-24
- Inventor: Shelley Allen , Laura L. Celeste , T. Gregg Davis , Robert Kirk DeLisle , Julie Marie Hicks , Stefan D. Gross , Erik James Hicken , Leila J. Jackson , Nicholas C. Kallan , Joseph P. Lyssikatos , Fredrik P. Marmsater , Mark C. Munson , Jed Pheneger , Bryson Rast , John E. Robinson , Stephen T. Schlachter , George T. Topalov , A. Dale Wright , Qian Zhao
- Applicant: Array BioPharma Inc.
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Viksnins Harris & Padys PLLP
- Agent Sarah S. Mastous
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/04 ; C07D451/06 ; C07D519/00
Abstract:
Provided herein is a method of treating a PIM-1 and/or PIM-2 and/or PIM-3 kinase-mediated condition in a mammal, which comprises administering to said mammal a therapeutically effective amount of a compound of Formula I: in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification.
Public/Granted literature
- US20140045817A1 TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS Public/Granted day:2014-02-13
Information query
IPC分类:
